Počet záznamů: 1
Serum Antibodies against Genitourinary Infectious Agents in Prostate Cancer and Benign Prostate Hyperplasia Patients: A Case-Control Study
- 1.
SYSNO ASEP 0356343 Druh ASEP J - Článek v odborném periodiku Zařazení RIV J - Článek v odborném periodiku Poddruh J Článek ve WOS Název Serum Antibodies against Genitourinary Infectious Agents in Prostate Cancer and Benign Prostate Hyperplasia Patients: A Case-Control Study Tvůrce(i) Hrbáček, J. (CZ)
Urban, M. (CZ)
Hamšíková, E. (CZ)
Tachezy, R. (CZ)
Eisenbruk, V. (CZ)
Brabec, Marek (UIVT-O) RID, SAI, ORCID
Heráček, J. (CZ)Zdroj.dok. Bmc Cancer. - : BioMed Central
Roč. 11, Art.no. 53 (2011), s. 1-10Poč.str. 10 s. Jazyk dok. eng - angličtina Země vyd. GB - Velká Británie Klíč. slova serum antibodies ; prostate cancer ; case-control study ; logistic regression, calibration Vědní obor RIV BB - Aplikovaná statistika, operační výzkum CEZ AV0Z10300504 - UIVT-O (2005-2011) UT WOS 000287365800002 EID SCOPUS 79551517297 DOI 10.1186/1471-2407-11-53 Anotace Infection plays a role in the pathogenesis of many human malignancies. Whether prostate cancer (PCa) - an important health issue in the aging male population in the Western world - belongs to these conditions has been a matter of research since the 1970s. Persistent serum antibodies are a proof of present or past infection. The aim of this study was to compare serum antibodies against genitourinary infectious agents between PCa patients and controls with benign prostate hyperplasia (BPH). We hypothesized that elevated serum antibody levels or higher seroprevalence in PCa patients would suggest an association of genitourinary infection in patient history and elevated PCa risk. Pracoviště Ústav informatiky Kontakt Tereza Šírová, sirova@cs.cas.cz, Tel.: 266 053 800 Rok sběru 2011
Počet záznamů: 1